Therefore, the ability of MDPs to interfere with the activation of these factors makes the use of natural marine products a promising anti-inflammatory therapeutic strategy for early-stage atherosclerosis, but requires further study into the long-term outcomes as well as off-target effects of NF-κB inhibition. Here, NFKB1 is linked to atherosclerosis.